Miracle woman who was told she would never walk again kicks off charity race

Miracle Milly, right, and her sisters <i>(Image: Simon Dack)</i>
Miracle Milly, right, and her sisters (Image: Simon Dack)

A miracle mum-of-two who was told she might never walk again kicked off a charity race.

Milly Hadden, from Storrington, was told she might never have children after battling cancer, sepsis and multiple organ failures but she defied the odds and sounded the horn with her two daughters at the Race for Life Pretty Muddy event in Stanmer Park, Brighton, on Sunday.

It saw hundreds climbing, crawling and sliding their way around obstacles to raise money for Cancer Research UK.

Miracle Milly, centre, her sisters and front, her mum Linsey and daughters Otillie, left, and Tallulah, right (Image: Simon Dack)

Among those taking part were Milly's younger sisters and their mum Linsey Mangion.

READ MORE: Miracle woman, 21, has two daughters after cancer, sepsis and stroke

Milly and her two-year-old Tallulah and one-year-old Otillie cheered them on from the sidelines.

After the race, Milly said: "Pretty Muddy was great fun. There was a great atmosphere – everyone taking part and all the staff and volunteers were lovely. A couple people came up to me and told me they had had the same experience with cancer and how lucky I was to have such a supportive family.

"We’ll definitely be doing Race for Life again next year."

The course took in fields and woodland and participants tackled five kilometres of challenging cross-country terrain.

Hundreds braved the mud and obstacles to raise money for Cancer Research UK (Image: Simon Dack)

Lynn Daly, Cancer Research UK’s Sussex spokeswoman, said: "We’re really grateful to Milly for her support and know her story will make an impact on people who hear it.

“No matter how cancer affects us, life is worth racing for. Sadly nearly one in two of us will get cancer in our lifetime. Race For Life has the power not only to transform lives, but to save them. We’re proud that Race for Life has already helped double survival rates in the UK."